Neuromyelitis optica spectrum disorder (NMOSD) patients have significantly poorer nutritional status than healthy people which is associated with worse…
Articles by Margarida Maia, PhD
The presence of certain self-reactive antibodies called antinuclear antibodies (ANAs) in the blood is associated with worse disability and more…
Long-term use of the approved therapy Soliris (eculizumab) safely and effectively prevents relapses in the real world in people…
The presence of lesions in the brain’s middle medulla, a control center for breathing, increases the likelihood of acute respiratory…
Having optic neuritis — inflammation of the nerves that relay information between the eyes and the brain — as a…
Achieving nine goals could help address inequities with access to properly diagnosing and treating neuromyelitis optica spectrum disorder (NMOSD),…
Uplizna (inebilizumab) reduces the number and size of subclinical lesions — those that cause no apparent symptoms — in…
Testing positive for self-reactive antibodies causing both neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD)…
Starting treatment with off-label rituximab soon after neuromyelitis optica spectrum disorder (NMOSD) symptoms begin may prevent long-term disability worsening,…
Neuromyelitis optica spectrum disorder (NMOSD) may begin to manifest as uncontrollable nausea, vomiting, or hiccups — a condition referred…